Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q4 2024
Institutional positions in Cidara Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +13 vs. Q3 2024
- Shares held
- 6.87M
- +3.57M (+107.8%) vs. Q3 2024
- Total value
- $183.6M
- +$148.1M (+416.3%) vs. Q3 2024
- New holders
- 17
- 14 more added
- Sold out
- 4
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 6 | $161 | 0.00% | −100−94.3% | Reduced |
| BNP Paribas Arbitrage, SA | 17 | $457 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 20 | $538 | 0.00% | +20 | New |
| Allworth Financial LP | 40 | $880 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 50 | $1.34K | 0.00% | +11+28.2% | Added |
| Point72 (DIFC) Ltd | 198 | $5.33K | 0.00% | +198 | New |
| Avion Wealth | 250 | $6.00K | 0.00% | 00.0% | Unchanged |
| Manchester Capital Management LLC | 470 | $12.6K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 2,085 | $56.0K | 0.01% | +2,085 | New |
| Morgan Stanley | 2,430 | $65.3K | 0.00% | +2,261+1,337.9% | Added |
| Point72 Asset Management, L.P. | 6,148 | $165.2K | 0.00% | +6,148 | New |
| Citigroup Inc | 7,584 | $203.9K | 0.00% | +7,584 | New |
| Omers Administration Corp | 12,600 | $338.7K | 0.00% | +12,600 | New |
| Jane Street Group, LLC | 12,714 | $341.8K | 0.00% | +12,714 | New |
| Goldman Sachs Group Inc | 13,870 | $372.8K | 0.00% | +13,870 | New |
| Alethea Capital Management, LLC | 14,311 | $384.7K | 0.33% | −65,597−82.1% | Reduced |
| Boothbay Fund Management, LLC | 15,601 | $419.4K | 0.01% | +15,601 | New |
| State Street Corp | 19,076 | $512.8K | 0.00% | +5,500+40.5% | Added |
| ADAR1 Capital Management, LLC | 24,938 | $670.3K | 0.14% | +24,938 | New |
| Northern Trust Corp | 33,957 | $912.8K | 0.00% | +2,170+6.8% | Added |
| Millennium Management LLC | 35,960 | $966.6K | 0.00% | +22,041+158.4% | Added |
| Susquehanna International Group, LLP | 42,623 | $1.15M | 0.00% | +42,623 | New |
| UBS Group AG | 46,871 | $1.26M | 0.00% | +40,994+697.5% | Added |
| StemPoint Capital LP | 47,642 | $1.28M | 0.32% | +47,642 | New |
| Schonfeld Strategic Advisors LLC | 49,557 | $1.33M | 0.01% | +30,057+154.1% | Added |
| Geode Capital Management, LLC | 53,068 | $1.43M | 0.00% | +170+0.3% | Added |
| Ikarian Capital, LLC | 53,940 | $1.45M | 0.41% | +53,940 | New |
| Acuta Capital Partners, LLC | 54,473 | $1.46M | 1.47% | +54,473 | New |
| BlackRock, Inc. | 55,525 | $1.49M | 0.00% | +6,605+13.5% | Added |
| 5AM Venture Management, LLC | 56,725 | $1.52M | 0.36% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 95,617 | $2.57M | 0.00% | −2,200−2.2% | Reduced |
| Checkpoint Capital L.P. | 196,949 | $5.11M | 2.60% | +14,523+8.0% | Added |
| Vanguard Group Inc | 217,504 | $5.85M | 0.00% | +36,969+20.5% | Added |
| Adage Capital Partners GP, L.L.C. | 369,954 | $9.94M | 0.02% | +327,199+765.3% | Added |
| Vivo Capital, LLC | 670,600 | $18.0M | 2.02% | +670,600 | New |
| Bain Capital Life Sciences Investors, LLC | 703,080 | $18.9M | 2.22% | 00.0% | Unchanged |
| VR Adviser, LLC | 765,723 | $20.6M | 1.41% | +765,723 | New |
| TCG Crossover Management, LLC | 1,005,901 | $26.1M | 2.55% | +1,005,901 | New |
| Ra Capital Management, L.P. | 1,092,796 | $29.4M | 0.39% | +389,716+55.4% | Added |
| BVF Inc | 1,092,796 | $29.4M | 1.00% | +389,731+55.4% | Added |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −369,099−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,115−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −855−100.0% | Sold out |
| Pacifica Partners Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |